Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02670902 · ClinicalTrials.gov registry record · NA
Intervention for Persons Leaving Residential Substance Abuse Treatment
A NA study, sponsored by New York University.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02670902: Completed NA study, sponsored by New York University.
NCT02670902 is a NA study that has completed, run by New York University. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02670902, a NA study, has completed, sponsored by New York University.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This research uses a multi-phase approach to adapt and implement an established intervention, Critical Time Intervention, for a new population and setting among individuals with substance use who are at risk of relapse following residential substance abuse treatment. The goals of the study are to: (PHASE 1) identify challenges and strategies of community reentry among individuals in residential substance abuse treatment and their providers and social support networks (e.g., family, friends, community members); (PHASE 2) adapt CTI for individuals in residential substance abuse treatment to prepare them for discharge and transition back into the community; and (PHASE 3) conduct a pilot study to examine the feasibility, acceptability, and preliminary outcomes of the adapted CTI compared to enhanced usual discharge planning services.
Primary Outcome
Proportion of participants enrolled in the study as measured by the research records
Interventions
- BEHAVIORAL Critical Time Intervention-Residential (CTI-R)
- BEHAVIORAL Enhanced Usual Discharge Services-Residential
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
What the finished NCT02670902 record still lists
NCT02670902 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Critical Time Intervention-Residential (CTI-R) is the first listed.
NCT02670902 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02670902 about?
NCT02670902 is a clinical study titled "Intervention for Persons Leaving Residential Substance Abuse Treatment". This research uses a multi-phase approach to adapt and implement an established intervention, Critical Time Intervention, for a new population and setting among individuals with substance use who are at risk of relapse following residential substance abuse treatment. The goals of the study are to: (...
What is the current status of trial NCT02670902?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2017-05-01. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT02670902?
The interventions under investigation include: Critical Time Intervention-Residential (CTI-R) (BEHAVIORAL), Enhanced Usual Discharge Services-Residential (BEHAVIORAL).
Who is sponsoring clinical trial NCT02670902?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02670902's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI